CCK receptor

CCK receptor

The peptide hormones cholecystokinin (CCK) and gastrin are bound by a class of G-protein coupled receptors known as cholecystokinin receptors. Cholecystokinin A receptor (CCK-AR), which is primarily found on pancreatic acinar cells, and CCK-BR, which is primarily found in the stomach and nervous system tissues, have both been identified as the endogenous receptors of CCK. Both have high affinity for gastrin, but only the CCK-BR has high affinity for the sulfated CCK octapeptide (CCK-8).

A peptide hormone called CCK was found in the small intestine. The traditional triad of gut hormones includes secretin, gastrin, and CCK. In addition to controlling gallbladder contraction, CCK also controls intestinal motility, satiety signaling, pancreatic enzyme secretion and growth, and the inhibition of gastric acid secretion. In central and intestinal neurons, CCK also functions as a transceiver.

CCK receptor related products

Structure Cat No. Product Name CAS No. Product Description
Caerulein (Caerulein; Cerulein; FI-6934) V12862 Caerulein (Caerulein; Cerulein; FI-6934) 17650-98-5 Caerulein (Caerulein; Cerulein; FI-6934) is a novel, potent and specific decapeptide-based cholecystokinin receptor agonist, it is produced in the skin of Hila caerulea, an Australian amphibian.
Loxiglumide V14030 Loxiglumide 107097-80-3 Loxiglumide is a potent, orally bioavailable, and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans.
Nastorazepide (Z-360) V26248 Nastorazepide (Z-360) 209219-38-5 Nastorazepide, formerly known as Z-360, is a selective, orally bioavailable, 1,5-benzodiazepine-analogue gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
Sincalide (CCK-8) V14810 Sincalide (CCK-8) 25126-32-3 Sincalide (CCK-8) is a cholecystokinetic drug used to treat cholecystitis and to diagnose disorders of the gallbladder and pancreas.
Contact Us